Aldeyra Therapeutics Is Severely Undervalued Before PDUFA March 5, 2025 / ALDX, Avisol Capital Partners Aldeyra Therapeutics Is Severely Undervalued Before PDUFA Read Post »ALDX, Avisol Capital Partners